INS and COVID-19: Alterations in cytokine and adipokine profiles such as those described in people with severe COVID-19 (107, 178, 179) are known to affect insulin signaling pathways and GLUT4 translocation and to impair insulin-mediated glucose uptake in skeletal muscle (282).